Download Files:
Products Details
Product Description
– JAK-IN-5 is an inhibitor of JAK extracted from patent US20170121327A1, compound example 283.
Web ID
– HY-111471
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C27H31FN6O
References
– [1]Paul R. Fatheree, et al. JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease. US20170121327A1|[2]Venkat R, et al. Methods of treatment using a jak inhibitor compound. US20180311226.
CAS Number
– 2096999-92-5
Molecular Weight
– 474.57
SMILES
– CN1CCC(N2CC(N=C(C3=NNC4=C3C=CC(C5=C(CC)C=C(O)C(F)=C5)=C4)N6)=C6CC2)CC1
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– JAK
Pathway
– Epigenetics;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK;Stem Cell/Wnt
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
